Joe Bennett MD
@JOEBENNETTMD
Followers
106
Following
587
Statuses
102
Hematology Oncology fellow at KUMC | Lymphoma | Father | Husband | Distance Runner
Joined March 2023
RT @SWOG: #myeloMATCH MM1YA-S01 is enrolling adults ages 18-59 with newly diagnosed high-risk #AML. Randomized 5-arm comparison of inductio…
0
7
0
RT @olsonplanner: 🚨 Sending some lunch money to some trainees 🚨 Are there 100 residents/fellows on this app who are working tonight? Bec…
0
28
0
On Wednesdays, the hematology consult team wears pink. Lots of compliments on the rounds today! @AYACOUB7
1
0
8
RT @Abdallah81MD: A huge shoutout to our amazing KU Heme Pharmacists! 🎉 They’ve put in so much effort this year, and we want to celebrate e…
0
4
0
@saraleidy_ @sghmd This is awesome. I’m proud of you. Great example of practicing what you preach in hematology.
0
0
3
RT @KUcancercenter: When your opponent is cancer, you want the best players to deliver the best outcome for you. That’s exactly what you’ll…
0
2
0
Great heme JC this evening moderated by the phenomenal @AtiehTahaniDO. Always great teaching and discussion with the KU leukemia team @LeukemiaMD, @LugoMd, Dr. Byrd, and Dr. Lin (author on the study)!
0
2
8
0
0
1
@INizMD @dgermain21 @NehaMehtaShahMD @SitemanCenter @WashUOncology @WashUHemOncFell Me too! Let’s do better for next ASH, I’ll buy the coffee. 😂
0
0
0
Mentorship in this field is important. Someone to help you along the journey. Grateful to be mentored by Dr. Marc Hoffmann, and honored to help mentor superstar resident @venkat28priya who is rising Hemeonc fellow at UAB! @UABHemOncFellow #ASH24
0
0
8
RT @Abdallah81MD: Dr. McGuirk our HMCT chair @KUcancercenter presenting during poster session at #ASH24 @ASH_hematology @mumairmushtaq @Nau…
0
6
0
EA4151 #LBA1 presented by @timfenske showing lack of benefit to autoSCT in MRD- MCL (by Clonoseq) in era of modern induction therapies! @KUcancercenter participated in this trial with @NausheenAhmedMD co-author on the study. MCL landscape changed significantly this #ASH24 #Lymsm
0
2
4
inMIND: R/R FL, Tafa+R2 vs R2, presented by @SehnLaurie , 57% reduction in risk of progression/relapse/death. PFS advantage met. I'm curious on antigen loss data as sequencing for CAR-T will be important. #LBA1 #ASH24 #Lymsm
0
3
10
RT @Abdallah81MD: Our outstanding pharmacist @j_snyder0132 delivered an impressive oral presentation on the real-world experience of infect…
0
8
0
Great oral abstract session by @j_snyder0132 covering T-cell engagers in NHL and MM and characterizing infectious complications. Data generated from @KUcancercenter to help guide practice and manage complications of therapy. @Abdallah81MD @NausheenAhmedMD @kczmj
0
4
9
RT @mshadman: Just out! Excited about our @JCO_ASCO manuscript published concurrently with our #ASH24 presentation. @fredhutch #CLL Zanu…
0
12
0
@thakkar_samarth @MidAmericaHeart @UMKCmedschool I did med school @UMKCmedschool great faculty and KC is a great place to live! :)
0
0
2
RT @majorajay: Retrospective maint R TRIANGLE #ASH24 - propensity scoring: PFS superior with RM - benefit of RM across all arms for PFS - n…
0
6
0